Corona Remedies Limited has scheduled its 22nd Annual General Meeting (AGM) for Thursday, July 9, 2026, at 11:00 a.m. IST. The meeting will be conducted via Video Conferencing (VC) and Other Audio Visual Means (OAVM), with the registered office serving as the deemed venue. The company has fixed Friday, June 19, 2026, as the record date to determine member entitlement for dividend for the financial year 2025-26, pending approval at the AGM.

The AGM convening notice and the Annual Report for FY 2025-26 will be dispatched electronically to members with registered email addresses. Additionally, these documents will be accessible on the company's website, the websites of BSE and NSE, and the Central Depository Services (India) Limited (CDSL) portal. Shareholders are required to update KYC details, including bank account information, to ensure the timely electronic disbursement of dividends as mandated by SEBI regulations effective April 1, 2024.

Key Meeting Details

The facility for e-voting will be provided to members, with detailed instructions included in the AGM notice. The company emphasized that physical presence at the venue is not required due to the virtual nature of the meeting. Members who have not registered their email IDs are advised to do so with their depository participants to receive corporate communications.

Source: https://lodr-files.dhan.co/lodr-inputs/Company/INE02ZQ01018/a70b7452781c41d3.pdf

CORONA Remedies Limited will participate in an investor conference in London on June 15 and June 16, 2026, to engage with institutional investors. The meetings, organized by Kotak Institutional Equities, are scheduled to commence at 09:00 AM British Summer Time (BST) onwards. The company clarified that discussions during these sessions will be restricted to publicly available information, ensuring no unpublished price sensitive information (UPSI) is disclosed.

The conference will include both 1x1 meetings and group interactions. The disclosure was made to the stock exchanges in compliance with Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

CORONA Remedies noted that the schedule is subject to change due to exigencies on the part of the host or the company. The intimation has been made available on the company's official website.